Clinical leadership High-value preventive cardiology practice led by Dr. Baum with deep expertise in lipid disorders and subclinical vascular disease, presenting a strong opportunity to cross-sell advanced lipid testing services, LDL-apheresis expertise, and high-end diagnostic imaging integrations.

Extended patient care Long in-person consultations and on-site imaging capabilities indicate a readiness to adopt companion digital health tools, remote monitoring programs, or onboarding services that streamline visit efficiency and support adherence to lifestyle interventions.

Specialized services On-site echocardiograms, nuclear stress tests, carotid ultrasounds, and FH-focused LDL-Apheresis position PCI as a potential adopter or partner for specialized medical devices, laboratory partnerships, and high-complexity lipid management solutions.

Financial scale Annual revenue in the low-to-mid single-digit millions with a lean team suggests opportunities for cost-effective software, billing optimization, revenue cycle management improvements, and scalable patient engagement platforms tailored to small-to-mid market practices.

Growth signals National Lipid Association fellowship and emphasis on cutting-edge, biomarker-driven risk assessment indicate openness to sponsorable educational events, clinical trial collaborations, and partnerships with health tech vendors targeting lipid and vascular risk management.